A Phase Ii Trial Of Cabozantinib (Cabo) For The Treatment Of Radioiodine (Rai)-Refractory Differentiated Thyroid Carcinoma (Dtc) In The First-Line SettingMarcia S. Brose,Sangeeta Shenoy,Nikhil Bhat,Anne K Harlacker,Raven K. Yurtal,Zakkiyya A Posey,Dena M Torrente,Carolyn Grande,Christian Michael Squillante,Andrea B. Troxel,Mark YarchoanJOURNAL OF CLINICAL ONCOLOGY（2018）引用 15|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
